Patents by Inventor Russell C. Petter

Russell C. Petter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20140073661
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: November 15, 2013
    Publication date: March 13, 2014
    Applicant: Celgene Avilomics Research, Inc.
    Inventors: Juswinder Singh, Shomir Ghosh, Arthur F. Kluge, Russell C. Petter
  • Pharmaceutical Formulations of Biodegradable Biocompatible Camptothecin-Polymer Conjugates
    Publication number: 20140004074
    Abstract: A camptothecin/polymer dual phase drug release system is described that is stable in both liquid and lyophilized states. The polymer contains acetals and/or ketals.
    Type: Application
    Filed: June 18, 2013
    Publication date: January 2, 2014
    Applicant: Mersana Therapeutics, Inc.
    Inventors: James Rolke, Russell C. Petter, Mao Yin, Aleksandr V. Yurkovetskiy, Gui Liu, Emile Farhan
  • Binding molecules and methods of use thereof
    Patent number: 8618042
    Abstract: Binding molecules are described.
    Type: Grant
    Filed: January 25, 2007
    Date of Patent: December 31, 2013
    Assignee: Biogen Idec MA Inc.
    Inventors: Julio H. Cuervo, Russell C. Petter, Daniel Scott, Kathryn Strauch
  • HCV PROTEASE INHIBITORS AND USES THEREOF
    Publication number: 20130338062
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: August 27, 2013
    Publication date: December 19, 2013
    Applicant: Celgene Avilomics Research, Inc.
    Inventors: Deqiang Niu, Russell C. Petter, Lixin Qiao, Juswinder Singh
  • 2,4-diaminopyrimidines useful as kinase inhibitors
    Patent number: 8609679
    Abstract: The present invention provides 2,4-diaminopyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: November 7, 2012
    Date of Patent: December 17, 2013
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • Heterocyclic compounds and uses thereof
    Patent number: 8586600
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: November 19, 2013
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Juswinder Singh, Shomir Ghosh, Arthur F. Kluge, Russell C. Petter
  • Polyal drug conjugates comprising variable rate-releasing linkers
    Patent number: 8524214
    Abstract: Polyal-Drug conjugates comprising a variable rate-releasing linker are described along with methods of making such conjugates. Uses for such Polyal-Drug conjugates is also described.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: September 3, 2013
    Assignee: Mersana Therapeutics, Inc.
    Inventors: Aleksandr Yurkovetskiy, Mao Yin, Gui Liu, Laura C. Akullian, John J. Kane, Cheri A. Stevenson, Charles E. Hammond, Russell C. Petter, John H. Van Duzer, Timothy B. Lowinger
  • Polyalkylene polymer compounds and uses thereof
    Patent number: 8524660
    Abstract: The invention relates to novel polyalkylene glycol compounds and methods of using them. In particular, compounds comprising a novel polyethylene glycol conjugate are used alone, or in combination with antiviral agents to treat a viral infection, such as chronic hepatitis C.
    Type: Grant
    Filed: September 12, 2011
    Date of Patent: September 3, 2013
    Assignee: Biogen Idec MA Inc.
    Inventors: KoChung Lin, R. Blake Pepinsky, Ling Ling Chen, Donna M. Hess, Edward Y. Lin, Russell C. Petter, Darren P. Baker
  • HCV protease inhibitors and uses thereof
    Patent number: 8524760
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: April 10, 2012
    Date of Patent: September 3, 2013
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Deqiang Niu, Russell C. Petter, Lixin Qiao, Juswinder Singh
  • Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates
    Patent number: 8491880
    Abstract: A camptothecin/polymer dual phase drug release system is described that is stable in both liquid and lyophilized states. The polymer contains acetals and/or ketals.
    Type: Grant
    Filed: December 10, 2009
    Date of Patent: July 23, 2013
    Assignee: Mersana Therapeutics, Inc.
    Inventors: James Rolke, Russell C. Petter, Mao Yin, Aleksandr Yurkovetskiy, Gui Liu, Emile Farhan
  • BIOCOMPATIBLE BIODEGRADABLE FUMAGILLIN ANALOG CONJUGATES
    Publication number: 20130158046
    Abstract: Fumagillin analog polymer conjugates, methods of making fumagillin analog polymer conjugates, compositions comprising a polymer conjugate of a fumagillin analog, and methods for treating cancer, or treating angiogenic diseases comprising administering to a subject in need thereof an effective amount of a polymer conjugate of a fumagillin analog, are described. Also described are novel fumagillin analogs, methods of making fumagillin analogs, compositions comprising at least one fumagillin analog, and methods for treating cancer, or treating angiogenic diseases comprising administering to a subject in need thereof an effective amount of a fumagillin analog.
    Type: Application
    Filed: February 15, 2013
    Publication date: June 20, 2013
    Applicant: Mersana Therapeutics, Inc
    Inventors: Laura C. Akullian, Russell C. Petter, John J. Kane, Charles E. Hammond, Mao Yin, Aleksandr Yurkovetskiy, Cheri A. Stevenson
  • 4,6-disubstituted pyrimidines useful as kinase inhibitors
    Patent number: 8445498
    Abstract: The present invention provides 4,6-disubstituted pyrimidine compound useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: February 1, 2011
    Date of Patent: May 21, 2013
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Juswinder Singh, Shomir Ghosh, Arthur F. Kluge, Russell C. Petter, Richland W. Tester
  • Biocompatible biodegradable fumagillin analog conjugates
    Patent number: 8399512
    Abstract: Fumagillin analog polymer conjugates, methods of making fumagillin analog polymer conjugates, compositions comprising a polymer conjugate of a fumagillin analog, and methods for treating cancer, or treating angiogenic diseases comprising administering to a subject in need thereof an effective amount of a polymer conjugate of a fumagillin analog, are described. Also described are novel fumagillin analogs, methods of making fumagillin analogs, compositions comprising at least one fumagillin analog, and methods for treating cancer, or treating angiogenic diseases comprising administering to a subject in need thereof an effective amount of a fumagillin analog.
    Type: Grant
    Filed: November 24, 2008
    Date of Patent: March 19, 2013
    Assignee: Mersana Therapeutics, Inc.
    Inventors: Laura C. Akullian, Russell C. Petter, John J. Kane, Charles E. Hammond, Mao Yin, Aleksandr Yurkovetskiy, Cheri A. Stevenson
  • HCV PROTEASE INHIBITORS AND USES THEREOF
    Publication number: 20130017991
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 17, 2013
    Applicant: CELGENE AVILOMICS RESEARCH, INC.
    Inventors: Deqiang Niu, Russell C. Petter, Juswinder Singh, Arthur F. Kluge, Lixin Qiao
  • 4,6-disubstitued pyrimidines useful as kinase inhibitors
    Patent number: 8329901
    Abstract: The present invention provides 4,6-disubstituted pyrimidine compound useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: February 1, 2011
    Date of Patent: December 11, 2012
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Juswinder Singh, Shomir Ghosh, Arthur F. Kluge, Russell C. Petter, Richland W. Tester
  • HCV protease inhibitors and uses thereof
    Patent number: 8309685
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: November 13, 2012
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Russell C. Petter, Juswinder Singh, Arthur F. Kluge, Deqiang Niu, Lixin Qiao, Shomir Ghosh
  • HCV protease inhibitors and uses thereof
    Patent number: 8293705
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: October 23, 2012
    Assignee: Avila Therapeutics, Inc.
    Inventors: Deqiang Niu, Russell C. Petter, Juswinder Singh, Arthur F. Kluge, Lixin Qiao
  • PI3 KINASE INHIBITORS AND USES THEREOF
    Publication number: 20120258967
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: March 8, 2012
    Publication date: October 11, 2012
    Applicant: AVILA THERAPEUTICS, INC.
    Inventors: Lixin Qiao, Deqiang Niu, Russell C. Petter, Zhengdong Zhu
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20120238593
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: May 31, 2012
    Publication date: September 20, 2012
    Applicant: AVILA THERAPEUTICS, INC.
    Inventors: Juswinder Singh, Shomir Ghosh, Arthur F. Kluge, Russell C. Petter
  • Heterocyclic compounds and uses thereof
    Patent number: 8242271
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: June 3, 2008
    Date of Patent: August 14, 2012
    Assignee: Avila Therapeutics, Inc.
    Inventors: Juswinder Singh, Shomir Ghosh, Arthur F. Kluge, Russell C. Petter